Abstract

Background: To evaluate the performance of a machine-learning (ML) algorithm to detect and classify choroidal neovascularization (CNV), secondary to age-related macular degeneration (AMD) on spectral-domain optical coherence tomography (SD-OCT) images. Methods: Baseline fluorescein angiography (FA) and SD-OCT images from 1037 treatment-naive study eyes and 531 fellow eyes, without advanced AMD from the phase 3 HARBOR trial (NCT00891735), were used to develop, train, and cross-validate an ML pipeline combining deep-learning–based segmentation of SD-OCT B-scans and CNV classification, based on features derived from the segmentations, in a five-fold setting. FA classification of the CNV phenotypes from HARBOR was used for generating the ground truth for model development. SD-OCT scans from the phase 2 AVENUE trial (NCT02484690) were used to externally validate the ML model. Results: The ML algorithm discriminated CNV absence from CNV presence, with a very high accuracy (area under the receiver operating characteristic [AUROC] = 0.99), and classified occult versus predominantly classic CNV types, per FA assessment, with a high accuracy (AUROC = 0.91) on HARBOR SD-OCT images. Minimally classic CNV was discriminated with significantly lower performance. Occult and predominantly classic CNV types could be discriminated with AUROC = 0.88 on baseline SD-OCT images of 165 study eyes, with CNV from AVENUE. Conclusions: Our ML model was able to detect CNV presence and CNV subtypes on SD-OCT images with high accuracy in patients with neovascular AMD.

Highlights

  • Detection of active choroidal neovascularization (CNV) is crucial for the timely treatment of neovascular age-related macular degeneration, in order to achieve a good outcome [1]

  • Clinicians are increasingly switching from fluorescein angiography (FA) to optical coherence tomography (OCT) for the diagnosis and management of neovascular age-related macular degeneration (nAMD), due to the advantages associated with OCT, including being noninvasive, enabling quick acquisition of retinal images with minimum technician training, and providing both qualitative and quantitative information [2,3,4]

  • Out of a total of 1098 patients randomized in HARBOR, baseline FA and spectral-domain optical coherence tomography (SD-OCT) images were available for 1037 study eyes

Read more

Summary

Introduction

Detection of active choroidal neovascularization (CNV) is crucial for the timely treatment of neovascular age-related macular degeneration (nAMD), in order to achieve a good outcome [1]. Patients with polypoidal choroidal vasculopathy (PCV) may benefit from combination therapy [6,7,8] In clinical trials, this information would help identify subgroups of patients with beneficial outcomes, with novel therapies [9]. To evaluate the performance of a machine-learning (ML) algorithm to detect and classify choroidal neovascularization (CNV), secondary to age-related macular degeneration (AMD) on spectral-domain optical coherence tomography (SD-OCT) images. Methods: Baseline fluorescein angiography (FA) and SD-OCT images from 1037 treatment-naive study eyes and 531 fellow eyes, without advanced AMD from the phase 3 HARBOR trial (NCT00891735), were used to develop, train, and cross-validate an ML pipeline combining deep-learning–based segmentation of SD-OCT B-scans and CNV classification, based on features derived from the segmentations, in a five-fold setting.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call